Seminars in Immunopathology

, Volume 37, Issue 2, pp 97–106 | Cite as

Pattern recognition receptors in antifungal immunity

  • Anthony Plato
  • Sarah E. Hardison
  • Gordon D. BrownEmail author
Open Access


Receptors of the innate immune system are the first line of defence against infection, being able to recognise and initiate an inflammatory response to invading microorganisms. The Toll-like (TLR), NOD-like (NLR), RIG-I-like (RLR) and C-type lectin-like receptors (CLR) are four receptor families that contribute to the recognition of a vast range of species, including fungi. Many of these pattern recognition receptors (PRRs) are able to initiate innate immunity and polarise adaptive responses upon the recognition of fungal cell wall components and other conserved molecular patterns, including fungal nucleic acids. These receptors induce effective mechanisms of fungal clearance in normal hosts, but medical interventions, immunosuppression or genetic predisposition can lead to susceptibility to fungal infections. In this review, we highlight the importance of PRRs in fungal infection, specifically CLRs, which are the major PRR involved. We will describe specific PRRs in detail, the importance of receptor collaboration in fungal recognition and clearance, and describe how genetic aberrations in PRRs can contribute to disease pathology.


C-type Lectin Dectin-1 Syk Antifungal Th17 

Fungi are usually efficiently cleared by an intact immune system; however, during immunosuppression, susceptibility to fungi increases and infection can be associated with high mortality rates [1]. Advances in medical technologies such as chemotherapy or indwelling medical devices and the appearance of immunosuppressive viruses such as HIV have led to a marked increase in the incidence of invasive fungal infection in the last several decades. Superficial infections in immunocompetent patients are also prevalent, including fungal keratitis and chronic skin diseases such as chromoblastomycosis [2, 3]. Coupled with the lack of reliable and swift identification methods and limited treatment options, incidence and morbidity due to fungal infections is currently at an unacceptably high rate.

Pattern recognition receptors (PRR) are germline-encoded receptors that recognise a variety of pathogen-associated molecules (pathogen-associated molecular patterns, PAMPs) expressed by an invading microorganism. These receptors induce downstream events designed to eliminate the pathogen from the host, including phagocytosis, respiratory burst, and cytokine and chemokine release. PRRs are best characterised into one of four families: the Toll-like (TLR), NOD-like (NLR), RIG-I-like (RLR) and C-type lectin-like receptors (CLR), each of which differ in ligand recognition, signal transduction and sub-cellular localisation. Most PRRs are expressed on dendritic cells (DCs) and other myeloid cells and are notable for initiating innate immune defences; however, PRR signalling can also direct the development of the adaptive immune response by secreting cytokines which polarise CD4+ T cells (T-helper or Th cells) [4, 5]. For fungi, Th1 and/or Th17 immunity is crucial for clearance of infection [6, 7].

Our current knowledge demonstrates that CLRs are the major receptor group for the recognition of fungi, while TLRs and NLRs play ancillary roles. This review will assess the current knowledge of selected PRRs in the pathogenesis of fungal infection, in particular how defects in host PRR signalling and immune evasion tactics allow fungal pathogens to thrive in the host.

C-type lectin-like receptors

CLRs are transmembrane receptors expressed on, but not restricted to, myeloid cells including macrophages and DCs. CLRs can also be found on lymphocytes, granulocytes, osteoclasts and epithelial cells [8, 9, 10, 11]. CLRs are able to recognise a diverse range of ligands via one or more C-type lectin-like domains (CTLD). Evolutionary diversion of this domain from the carbohydrate recognition domain (CRD) of classical C-type lectins has allowed them to recognise a range of molecules including carbohydrates, lipids and proteins [11, 12]. CLRs recognise both endogenous and exogenous ligands in the regulation of homeostasis and immunity, utilising spleen tyrosine kinase (syk) as a primary signal transduction molecule. Signalling commonly requires an immunoreceptor tyrosine-based activation motif (ITAM) or ITAM-like motif which is phosphorylated at tyrosine(s) within the consensus sequences (YxxI/L (6–12)YxxI/L) and (YxxI/L) respectively. This motif can be present within the signalling tail of the receptor itself or an associated adapter chain such as FcRγ. As well as cellular activation, many CLRs can perform inhibitory roles by utilising an immunoreceptor tyrosine-based inhibitory motif (ITIM). Phosphorylation of the central tyrosine within the consensus sequence (I/V/L/SxYxxI/L/V) is involved in the recruitment of tyrosine phosphatases, exhibiting regulatory effects on other activation pathways [13].

Current understanding is that ITAM motifs are phosphorylated by Src family kinase members, allowing the recruitment and subsequent activation of syk. A large network of proteins including phospholipase Cγ2 (PLCγ2), protein kinase Cδ (PKCδ), IκB kinase (IKK) and the CARD9-Bcl10-MALT1 complex is known to exist downstream of syk and upon activation, these molecules regulate effects specific to each receptor [14]. The CLRs Dectin-1, Dectin-2, CLEC-9A, CLEC-2, and macrophage-inducible C-type lectin (Mincle) signal via syk, but their biological roles can differ greatly. Currently, CLEC-9A and CLEC-2 are known to have important roles in cell damage detection and platelet activation, respectively, whereas Dectin-1, Dectin-2 and Mincle play major roles fungal and bacterial infections [14, 15]. On the other hand, ligand binding to ITIM-containing receptors results in ITIM phosphorylation and the association of SH2-domain-containing protein tyrosine phosphatases including (SHP)-1 and SHP-2, that are able to directly regulate signalling downstream of ITAM motifs. CLRs such as DCIR, MICL and MAH contain ITIM motifs [14]; however, in this review, we will focus on the activation of CLRs related to fungal disease (Fig. 1).
Fig. 1

Examples of activation signals initiated by CLRs: both Dectin-1 and Dectin-2 signal via tyrosine-based motifs (ITAM-like and FcRγ-associated ITAM, respectively) where recruitment of syk directly to phosphorylated tyrosine residues results in downstream activation of the CARD9-Bcl10-Malt1 complex. DC-SIGN contains no tyrosine-based motifs but is able to induce phosphorylation and acetylation of NF-κB subunit p65 via the assembly of signalosome. DC-SIGN activation of p65 is Raf-1-dependent


Dectin-1 is a well-defined CLR that recognises β-1,3-glucans present in the cell wall of Aspergillus, Candida and many other fungal species [8, 16]. Dectin-1 contains a single CTLD that is able to recognise fungal β-glucans and undefined ligands on mycobacteria and T cells, although vimentin was recently identified as possible endogenous Dectin-1 ligand [17]. Upon ligand recognition, Dectin-1 signals through the syk/CARD9 pathway via an ITAM-like motif. This motif is present in the intracellular signalling tail of Dectin-1 and uses a single phosphorylatable tyrosine residue to recruit syk to dimerised Dectin-1 [18]. Through phosphorylation of phospholipase C (PLC)γ2 and subsequent activation of protein kinase C (PKC), syk activates the CARD9-Bcl10-MALT1 complex to induce canonical NF-κB activation. Syk can also induce non-canonical NF-κB activation through NK-κB-inducing kinase (NIK) [19, 20, 21]. These pathways induce cytokine and chemokine production including TNF, IL-2, IL-10, CXCL2 as well as IL-1β, IL-6 and IL-23, key cytokines in the development of the antifungal Th17 response, as discussed later [22, 23, 24]. Dectin-1 also induces phagocytosis, respiratory burst and other antimicrobial effector mechanisms such as activation of the NLRP3 inflammasome via ERK-induced reactive oxygen species (ROS) production [14, 25]. The role of the inflammasome in antifungal immunity will be discussed in more detail later [26].

The importance of Dectin-1 in the control of fungal infections is highlighted by the susceptibility of Dectin-1-deficient mice to infection with Candida albicans, Aspergillus fumigatus and Pneumocystis carinii [22, 27, 28]. Interestingly, the degree of susceptibility is strain-dependent in the case of C. albicans [29]. Furthermore, Dectin-1 deficiency in humans can lead to susceptibility to certain fungal infections including chronic mucocutaneous candidiasis and recurrent vulvovaginal candidiasis [30, 31]. Both of these infections occur more frequently in patients containing a mutation in Dectin-1 (Y238X) which results in the production of a truncated protein. This truncation results in a loss of function and as such, monocytes and macrophages from patients with this polymorphism are deficient in cytokine secretion following stimulation with particulate β-glucan or C. albicans [30]. The Y238X polymorphism has also been shown in some studies to be associated with susceptibility to invasive aspergillosis with defective IFNγ, IL-10, IL-1β, IL-6 and IL-17 responses [32]. Recently, a polymorphism in Dectin-1 was identified that is associated with severe, intractable forms of ulcerative colitis resulting from improper recognition of fungal gut microbes [33].

Predisposition to fungal infections can also be seen in CARD9-deficient humans. CARD9 deficiency has been studied in a family in which eight members were affected with a mutation causing a premature stop codon (Q295X), resulting in a truncated protein [31]. Three of these individuals died from invasive candida infections of the brain in early childhood, while four family members were affected by recurrent mucocutaneous candidiasis.


The roles of Dectin-2 and Mincle in immunity are well-characterised, and both recognise fungi. Unlike Dectin-1, the CTLD of Dectin-2 is more like a classical CRD, containing the short Glu-Pro-Asn (or EPN) motif that recognises mannose structures in a calcium-dependent manner. For both Dectin-2 and Mincle, surface expression and signal transduction require an associated FcRγ signalling adapter that contains an ITAM motif. The two tyrosines within the ITAM consensus sequence are phosphorylated by Src family kinases, allowing recruitment of syk to the activated receptor and signalling via the CARD9-Bcl10-MALT1 complex. Cytokine transcription is initiated via ERK, p38 and MAP kinases [15, 34].

Dectin-2 has been shown to recognise C. albicans, A. fumigatus, Saccharomyces cerevisiae, Cryptococcus neoformans, Histoplasma capsulatum, Trichophyton rubrum, Microsporum audouinii and Malassezia spp. Dectin-2−/− bone marrow-derived dendritic cells (BMDC) are unable to induce cytokine responses to C. albicans, including IL-1β, IL-6, TNF, IL-12p40 and IL-10, and Dectin-2−/− mice are more susceptible to C. albicans infection. Furthermore, Dectin-2−/− mice are deficient in Th17 polarisation in response to C. albicans, an effect dependent on the syk/CARD9 pathway [35]. Activation of Dectin-2 on human DCs selectively activates the NF-κB subunit c-Rel via Malt1 activation. This is unlike Dectin-1, where ligand recognition results in activation of all NF-κB subunits [21, 34]. MALT1/c-Rel activation by Dectin-1 and Dectin-2 was shown to be important for the induction of a Th17 response [34, 35, 36]. Susceptibility to fungal disease due to Dectin-2 polymorphisms has not yet been described in humans.

While Mincle is primarily known for its role in recognising mycobacteria, this CLR is also able to recognise fungal species including Candida, Malassezia and Fonsecaea species [1, 37]. Recognition of these fungi by Mincle can lead to phagocytosis, fungal killing and induction of TNF, IL-6, MIP-2 and KC in macrophages [15, 38, 39], and clearance of murine Fonsesaea pedrosoi infection is dependent on Mincle [40]. The role of Mincle in anti-Candida immunity is controversial, with contrasting data on the importance of this receptor in vivo [38, 41]. Similarly to Dectin-2, there are no known human polymorphisms in Mincle that lead to susceptibility to fungi.


Dendritic cell-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN, murine homolog SIGNR1) is a transmembrane CLR that contains a single CRD that recognises carbohydrate-based ligands including mannose and fucose structures. Unlike the other C-type lectins already discussed, DC-SIGN does not have tyrosine-based signalling motifs within its intracellular tail, instead it contains di-leucine (LL) and tri-acidic (EEE) motifs. Very little is known about the signal transduction pathways utilised by DC-SIGN; however, it has been shown that DC-SIGN can activate Raf-1, a serine/threonine MAP kinase that is involved in the acetylation the NF-κB subunit, p65. Interestingly, this acetylation only takes place on p65 molecules that were previously activated by TLRs. This acetylation enhances and prolongs transcription of the IL-10 gene, leading to an enhanced anti-inflammatory response [42]. Interactions of CLRs and TLRs such as this are crucial to antifungal immunity, and will be discussed in greater detail in following sections [14, 24, 42, 43].

The ability of DC-SIGN to recognise varied carbohydrate structures allows it to differentiate between diverse organisms such as C. albicans, Mycobacterium tuberculosis, HIV-1, or Helicobacter pylori, allowing a tailored response to each through the formation of the DC-SIGN signalosome (Fig. 2). The DC-SIGN signalosome is a complex required for the constitutive association of DC-SIGN with Raf-1. This complex is made up of the scaffold proteins LSP1, KSR1 and CNK, and the association or dissociation of this complex allows varying inflammatory responses depending on the ligand associated. For example, IL-10, IL-12 and IL-6 expression is observed upon mannose recognition. Here, recruitment of LARG and RhoA to the signalosome results in activation of Ras and Raf-1 for the regulation of TLR4 pathways. On the other hand, fucose stimulation of DC-SIGN results in the dissociation of this complex and the down-regulation of IL-6 and IL-12 in an LSP-dependent manner. [43]. Interestingly, DC-SIGN can also cooperate with the mannose receptor (MR) to repress Dectin-1-dependent Th17 development in human DCs upon stimulation with either β-glucans or M. tuberculosis [44].
Fig. 2

DC-SIGN pathogen recognition determines downstream TLR regulation. Formation or disassembly of the DC-SIGN signalosome is able to tailor TLR signalling pathways towards a more effective response to each pathogen encountered. This is a novel mechanism for pathogen differentiation including potential fungal mannan-induced signalling

DC-SIGN is also able to recognise A. fumigatus, and human polymorphisms in DC-SIGN cause increased susceptibility to invasive pulmonary aspergillosis (IPA), a life-threatening infection of respiratory tracts often seen in patients with neutropenia or other immunosuppression [45, 46]. Several single nucleotide polymorphisms (SNPs) were shown to increase the risk of developing IPA by 2-fold in patients that had undergone haematopoietic stem cell transplantation (HSCT) or chemotherapy.

Mannose receptor

The MR is a CLR that recognises multiple fungi, bacteria and viruses via eight extracellular CTLDs. Specifically, the CTLD recognises terminal mannose and fucose-based structures as well as N-acetyl glucosamine [24]. Unlike the other CLRs discussed here, the MR extracellular domain can be cleaved by a metalloproteinase to form soluble MR (sMR). MR shedding was shown to be induced by Dectin-1 recognition of zymosan, C. albicans, A. fumigatus and cell wall components of S. cerevisiae. Interestingly, sMR is still able to recognise pathogen and host molecules [47]. The MR is able to induce ROS and cytokine production; however, as its signalling tail lacks known motifs; it is thought that responses to C. albicans involve collaboration with Dectin-1 and peroxisome proliferator activated receptor γ (PPARγ) [48]. MR is known to play a role in the development of Th17 responses to C. albicans; however, MR knockouts are not susceptible to C. albicans infection [49].

TOLL-like receptors

Although CLRs are considered to be the primary receptor class for fungal recognition, members of the TLR family and their interactions with CLRs are critical to antifungal immunity. TLRs are considered to be the most well-defined of the four families of PRRs. There are 13 members in mice, and TLR1-10 are expressed in humans. All of these members are transmembrane receptors expressed either at the cell surface, in the case of TLR1, 2, 4, 5, 6 and 10, or on intracellular membranes in the case of TLR3, 7, 8, 9. Transmembrane TLRs recognise PAMPs present in cell walls and membranes, for example, lipopolysaccharide (LPS) and peptidoglycan, which are recognised by TLR4 and TLR2, respectively. Alternatively, TLRs present on intracellular membranes recognise fungal, bacterial and viral nucleic acids within an infected cell. TLRs (with the exception of TLR3) are all able to signal through MyD88, which has been shown to be crucial in the clearance of infections. MyD88−/− mice have been shown to be sensitive to fungal infections, including C. albicans and A. fumigatus, and MyD88 is required for optimal Th1 responses to fungi in mice [50].

Individually, TLR2, 4, 7 and 9 have been shown to play roles in C. albicans infections in mice. TLR4-defective (C3H/HeJ) mice are more susceptible to disseminated candidiasis, characterised by increased kidney fungal burdens and reduced neutrophil recruitment [51]. Similarly, TLR2−/− mice are susceptible to systemic challenge with C. albicans. [52]. It should be noted, however, that TLR recognition of different C. albicans strains as well as other fungi is highly variable, leading to some confusion in the literature [53]

In humans, complete lack of TLR functionality, through mutation of key downstream signalling adaptors such as MyD88 does not predispose individuals to fungal infections [54]. This demonstrates that TLRs are not the central PRRs involved in antifungal immunity in humans. However, in immunocompromised hosts, polymorphisms in the TLR genes can result in a predisposition to fungal infections [55, 56, 57, 58]. For example, D299G polymorphism in TLR4 increases susceptibility to chronic cavity pulmonary aspergillosis (CCPA), a subacute cavity-forming aspergillosis. Interestingly, TLR2 SNPs showed no susceptibility to CCPA but a potentially protective role in allergic bronchopulmonary aspergillosis (ABPA), whereas patients suffering from ABPA had significantly higher frequency of a TLR9 SNP (T-1237C) compared to unaffected controls [58].

Collaboration between CLRs and TLRs

TLRs and CLRs are both required for antifungal responses, and these pathways interact to induce optimal immunity dependent on Syk/CARD9 and MyD88 signalling pathways [1, 59, 60]. For example, co-stimulation with both Dectin-1 and TLR2 or TLR4 ligands leads to a synergistic increase in TNF, IL-10 and IL-23 and a decrease in IL-12 production (Fig. 3) [1, 60, 61]. SIGNR1, a murine homolog of DC-SIGN, also collaborates with TLRs in the recognition of C. albicans. Recent studies have demonstrated that SIGNR1 suppresses the function of TLR2 by down-regulating TNF, IL-6, IL-12p40 and FSL-1-mediated activation of NF-κB [62]. However, in collaboration with TLR2 and Dectin-1, SIGNR1-expressing macrophages were shown to induce TNF production [63]. These functions are not abolished by mutation of the SIGN-R1 intracellular tail, suggesting no signalling role for SIGN-R1; however, the overall mechanism is still unclear [63, 64]. It is hypothesised that this receptor aids binding of fungi at the cell surface, or that it interacts with other receptors at the site of microbe contact.
Fig. 3

Dectin-1 and Dectin-2 contribute to T cell differentiation: Dectin-1 and Dectin-2 are able to induce Th17-polarising cytokine secretion from DCs upon ligand activation and subsequent syk/CARD9 activation. As well as this IL-17 production can be directly induced by Dectin-1 activation from γδ T cells, increasing anti-fungal activity

Modulating CLR and TLR collaboration has been utilised therapeutically in the treatment of fungal infections, such as for the clearance of F. pedrosoi from infected mice. F. pedrosoi is the causative agent of the chronic skin disease chromoblastomycosis, and is recognised by Mincle. Patients with severe F. pedrosoi infection may have prolonged antifungal treatment courses [65]; however, recent studies have shown that application of topical TLR7 ligand, imiquimod, results in rapid clearance of infection in mice as well as small cohort of human patients [1, 37, 40]. Similar observations of CLR and TLR collaboration were made for the reduction of P. carinii lung burden in mice. Treatment with aerosolised heat-killed E. coli was able to induce clearance of the infection, likely through Dectin-1 and TLR2 collaboration [66, 67].

Recently, collaboration between different CLRs has also been described. For example, Mincle and Macrophage C-type lectin (MCL, also CLECSF8 or CLEC4D) form a receptor complex with the signalling adaptor FcRγ to induce downstream signalling through syk/CARD9. Both receptors and FcRγ were shown to be required for optimal phagocytosis [68, 69]. Furthermore, Mincle activation was recently shown to inhibit Dectin-1 induced proinflammatory responses [70]. Further investigation of multiple CLR interactions may answer questions about other instances of modified ligand recognition during receptor complex formation.

NOD-like receptors

NLRs are cytoplasmic receptors that recognise PAMPs of internalised microbial components. Currently, there are 23 known human NOD-like receptors that are broadly categorised into two subfamilies: the NOD subfamily, characterised by the presence of one or more CARD domain, and the NOD leucine-rich repeat and pyrin domain-containing protein (NLRP) subfamily characterised by the presence of a pyrin domain. Notable members of the NOD subfamily include NOD1 and NOD2. These receptors are well studied, in particular the role of NOD2 in Crohn’s disease; however, the receptors of importance in antifungal immunity are those that form an inflammasome complex. Inflammasomes are innate immune complexes that cleave pro-IL-1β and pro-IL-18 into their biologically active forms. Cleavage of pro-IL-1β/18 is often considered the secondary signal to IL-1β/18 production, the first signal being PAMP recognition and production of pro-IL-1β/18 by NF-κB activation [26, 71]. NLRs capable for forming inflammasomes include NLRP1, 2, 3, 6, 7 and NLRC4 and 5 where, upon ligand activation, they associate with ASC and caspase-1 to form the basis of the inflammasome [72].

Although its ligand is yet to be defined, NLRP3 is a well-studied inflammasome NLR and is known to contribute to antifungal immunity [26, 71, 73]. Observations of NLRP3 revealed that it is essential in the control of mucosal and disseminated C. albicans infections by the processing of pro-IL-1β to IL-1β downstream of Dectin-1 and TLR2 [71]. Importantly, NLRP3 recognition of C. albicans requires the fungus to be in a filamentous state, as C. albicans incapable of forming hyphae do not induce this response [74]. Both caspase-1−/− and ASC−/− mice were susceptible to C. albicans infection compared to wild-type mice, likely due to increased fungal burdens in both knockouts as well as tissue invasion in the caspase-1−/− mice. Reduced IL-1 and IL-17 were found at the site of infection as well as little neutrophil infiltration. BMDCs from these knockouts also showed defective production of IL-1β and IL-18, cytokines responsible for Th17 and Th1 polarisation, respectively, suggesting that the NLRP3 inflammasome can control T-helper responses to C. albicans infection [75]. NLRP3 has also been shown to induce IL-1β maturation in response to A. fumigatus hyphae and relies upon Dectin-1 activation of Syk as well as ROS production and K + efflux [73]. Furthermore, using bone marrow chimera studies, NLRC4 has been demonstrated to be important for controlling candida infection at mucosal sites [76].

Interestingly, the caspase-8 inflammasome is able to induce IL-1β independently of NLRs in a manner directly through Dectin-1 signalling. In contrast to the NLRP3 inflammasome, caspase-8 and ASC are recruited directly to the CARD9-Bcl10-MALT1 signalling complex, where IL-1β cleavage takes place. This pathway also activates the non-canonical NF-κB subunit c-Rel which induces transcription of the IL1β gene, allowing an effective antifungal response through rapid IL-1β production [77].

The TH17 response in antifungal immunity

Th17 cells are a subset of CD4+ T cells involved in protective immunity to fungal infections, and these responses appear to be primarily triggered through CLRs. Defects in Th17 defence often result in recurring fungal infection and autoimmune disease [24, 78, 79]. Differentiation and development of Th17 cells requires TGF-β, IL-6 and IL-21 along with IL-23 for growth and increased Th17 response. Transcription factors including signal transducer and activator of transcription 3 (STAT3), RAR-related orphan receptor (ROR)α and RORγt are also required for Th17 development and maintenance [80, 81]. Th17 cells produce the cytokines IL-17A and F that bind the IL-17 receptor and induce the secretion of proinflammatory factors including IL-6, IL-8 and GM-CSF as well as the chemokines CXCL1 and CCL20, which are involved in macrophage and neutrophil recruitment [82]. This strong proinflammatory effect can be seen in stromal cells of almost all tissues [83].

CLRs are critical to the development of Th17 cells during infection. In particular, Dectin-1 is able to regulate differentiation of CD4+ T cells into Th17 cells by inducing DC activation through recognition of β-glucan and cytokine production. This is dependent on both syk/CARD9 and Raf-1 pathways where Th17-promoting cytokines IL-1β, IL-6 and IL-23 are increased and Th1-promoting cytokine IL-12 is decreased [60, 84]. Dectin-2 shows a similar cytokine profile upon recognition of C. albicans, and when blocked, IL-17 production from T cells was prevented, suggesting Dectin-2 plays a pivotal role in Candida-specific Th17 responses [34, 35]. Dectin-1-expressing T cell receptor gamma-delta (TCRγδ) T cells have also been shown to induce production of IL-17 upon stimulation with β-glucan and curdlan. These γδ T cells are thought to be important during an early innate response, as they are potent sources of IL-17. The innate response can be further amplified in the presence of IL-23, increasing IL-17 production, T cell expansion and neutrophil recruitment [85, 86]. Additionally, IL-17 can stimulate epithelial cells to produce neutrophil-recruiting chemokines and antimicrobial peptides such as β-defensin and the S100A proteins [87].

Evidence of a protective role for Th17 cells have been shown for multiple murine studies; however, it is apparent that uncontrolled Th17 inflammation is deleterious. A lack of Th17 polarisation leads to increased susceptibility to fungal infections. For example, IL-23p19−/− mice, which are Th17 impaired, lack effective clearance of P. carinii as well as reduced CD4+ T cells in the lungs [88]. IL-17A receptor-deficient mice are severely impaired for clearance of C. albicans, and increased mortality is observed in a model of systemic candidiasis. Alternatively, driving Th17 responses during C. albicans infection reduces Th1 immunity and results in generalised neutrophilic inflammation which exacerbates disease [89]. Th17 differentiation in response to C. albicans is initiated by Dectin-1 via the syk-CARD9 complex, and is independent of TLR signalling. Recently, deficiencies in neutrophil recruitment to sites of infection have been observed in an oropharyngeal candidiasis (OPC) model in IL-17AR−/− and IL-23−/− mice [90]. Neutrophils exhibit IL-17 autocrine activity that induces innate responses such as ROS production and increased fungal killing. These responses are induced by IL-6 and IL-23, and were completely dependent on RORγt, suggesting the importance of neutrophils in Th17 responses [2]. Recently, IL-17 was shown to be important for controlling the ability of NK cells to produce GM-CSF, a cytokine required to promote neutrophil antifungal activities and essential for the control of systemic Candida infections [91]. In humans, polymorphisms in genes which regulate Th17 differentiation, such as IL-17, IL-17RA, STAT1 or STAT3, result in susceptibility to mucocutaneous candidiasis, demonstrating the essential nature of this pathway in antifungal defence [92, 93, 94].

Immune evasion

Fungi can utilise differential expression of PAMPs to evade recognition by the immune system. Masking or modification of cell wall components can prevent PRR recognition. β-1,3-glucans are highly immunostimulatory and are often masked by less immunogenic structures in the outer cell wall [95]. For example, C. albicans is able to mask β-1,3-glucan under a layer of mannoproteins, preventing recognition by Dectin-1. Although mannoproteins themselves are immunostimulatory, it appears that the lack of β-glucan exposure results in a defective co-stimulatory response between Dectin-1 and TLR2/4 [96]. Surface β-glucan exposure is increased at bud scar; however, it is masked by mannans in the hyphal form. Growth in the hyphal form could be seen as an evasion tactic, as Dectin-1 has a reduced affinity for hyphal C. albicans compared to the yeast form [97, 98]. In contrast, Dectin-2 can also recognise C. albicans, but is thought to preferentially bind the hyphal morphology [99].

Masking of immunostimulatory molecules is observed in other species of pathogenic fungus. For example, H. capsulatum, the causative agent of the pulmonary disease histoplasmosis, employs α-1,3-glucans to cover the β-1,3-glucan underneath. In the presence of this α-glucan layer, TNF production is suppressed, suggesting this is an effective mechanism in reducing proinflammatory responses [100]. Alternatively, P. brasiliensis, a fungus known to cause the systemic infection paracoccidioidomycosis, reduces PAMP surface expression by converting the cell wall glucan linkage from β-1,3 to α-1,3-glucans during its transition into pathogenic yeast form. C. neoformans also evades immune surveillance by masking its PAMPs under a thick layer of polysaccharides known as the capsule. Control of the capsule’s structure allows C. neoformans to survive extracellular stresses [101]. Acapsular mutants of C. neoformans are avirulent, demonstrating the efficacy of the capsule in preventing efficient clearance from the host [102]. Interestingly, the capsule can also bind mannan-binding lectin, preventing complement activation [103, 104].


PRRs are the first line of defence in antifungal immunity. Upon recognition of surface-expressed PAMPs such as β-glucan and α-mannan, CLRs initiate inflammatory innate responses that in turn polarise a Th17 adaptive immune response which is generally beneficial to fungal control and clearance. When these immune defences fail, such as in immunocompromised hosts, opportunistic fungal pathogens are able to establish potentially life-threatening infections. Our current understanding of receptor partnering is developing, and future work may shed light on how cooperation between CLRs and TLRs collectively recognises different microbes and shape the development of immunity. It is clear that host-pathogen interactions are highly complex, and understanding these mechanisms will be crucial in developing effective treatments against fungal infections in the future.



We thank the Wellcome Trust for funding this study.

Conflict of interest

The authors report no conflict of interest. The authors alone are responsible for the content and writing of the paper.


  1. 1.
    Hardison SE, Brown GD (2012) C-type lectin receptors orchestrate antifungal immunity. Nat Immunol 13:817–22CrossRefPubMedCentralPubMedGoogle Scholar
  2. 2.
    Taylor PR, Roy S, Leal SM, Jr., Sun Y, Howell SJ, et al. Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORgammat and dectin-2. Nat Immunol 15: 143–51Google Scholar
  3. 3.
    Seyedmousavi S, Netea MG, Mouton JW, Melchers WJ, Verweij PE et al (2014) Black Yeasts and their filamentous relatives: principles of pathogenesis and host defense. Clin Microbiol Rev 27:527–42CrossRefPubMedGoogle Scholar
  4. 4.
    Medzhitov R (2009) Approaching the asymptote: 20 years later. Immunity 30:766–75CrossRefPubMedGoogle Scholar
  5. 5.
    Gordon S (2002) Pattern recognition receptors: doubling up for the innate immune response. Cell 111:927–30CrossRefPubMedGoogle Scholar
  6. 6.
    Savina A, Amigorena S (2007) Phagocytosis and antigen presentation in dendritic cells. Immunol Rev 219:143–56CrossRefPubMedGoogle Scholar
  7. 7.
    Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245–52CrossRefPubMedGoogle Scholar
  8. 8.
    Brown GD, Gordon S (2001) Immune recognition. A new receptor for beta-glucans. Nature 413:36–7CrossRefPubMedGoogle Scholar
  9. 9.
    Inui M, Kikuchi Y, Aoki N, Endo S, Maeda T et al (2009) Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12. Proc Natl Acad Sci U S A 106:4816–21CrossRefPubMedCentralPubMedGoogle Scholar
  10. 10.
    Kerrigan AM, Brown GD (2009) C-type lectins and phagocytosis. Immunobiology 214:562–75CrossRefPubMedCentralPubMedGoogle Scholar
  11. 11.
    Sancho D, Reis E, Sousa C (2012) Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu Rev Immunol 30:491–529CrossRefPubMedGoogle Scholar
  12. 12.
    Zelensky AN, Gready JE (2005) The C-type lectin-like domain superfamily. FEBS J 272:6179–217CrossRefPubMedGoogle Scholar
  13. 13.
    Redelinghuys P, Brown GD (2011) Inhibitory C-type lectin receptors in myeloid cells. Immunol Lett 136:1–12CrossRefPubMedCentralPubMedGoogle Scholar
  14. 14.
    Plato A, Willment JA, Brown GD. C-type lectin-like receptors of the dectin-1 cluster: ligands and signaling pathways. Int Rev Immunol 32: 134–56Google Scholar
  15. 15.
    Kerscher B, Willment JA, Brown GD. The Dectin-2 family of C-type lectin-like receptors: an update. Int Immunol 25: 271–7Google Scholar
  16. 16.
    Brown GD (2006) Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol 6:33–43CrossRefPubMedGoogle Scholar
  17. 17.
    Thiagarajan PS, Yakubenko VP, Elsori DH, Yadav SP, Willard B et al (2013) Vimentin is an endogenous ligand for the pattern recognition receptor Dectin-1. Cardiovasc Res 99:494–504CrossRefPubMedCentralPubMedGoogle Scholar
  18. 18.
    Kerrigan AM, Brown GD (2010) Syk-coupled C-type lectin receptors that mediate cellular activation via single tyrosine based activation motifs. Immunol Rev 234:335–52CrossRefPubMedGoogle Scholar
  19. 19.
    Geijtenbeek TB, Gringhuis SI (2009) Signalling through C-type lectin receptors: shaping immune responses. Nat Rev Immunol 9:465–79CrossRefPubMedGoogle Scholar
  20. 20.
    Gross O, Gewies A, Finger K, Schafer M, Sparwasser T et al (2006) Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 442:651–6CrossRefPubMedGoogle Scholar
  21. 21.
    LeibundGut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC et al (2007) Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 8:630–8CrossRefPubMedGoogle Scholar
  22. 22.
    Reid DM, Gow NA, Brown GD (2009) Pattern recognition: recent insights from Dectin-1. Curr Opin Immunol 21:30–7CrossRefPubMedCentralPubMedGoogle Scholar
  23. 23.
    Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R et al (2009) Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30:576–87CrossRefPubMedCentralPubMedGoogle Scholar
  24. 24.
    Vautier S, Sousa Mda G, Brown GD (2010) C-type lectins, fungi and Th17 responses. Cytokine Growth Factor Rev 21:405–12CrossRefPubMedCentralPubMedGoogle Scholar
  25. 25.
    Poeck H, Ruland J (2010) SYK kinase signaling and the NLRP3 inflammasome in antifungal immunity. J Mol Med (Berl) 88:745–52CrossRefGoogle Scholar
  26. 26.
    Gross O, Poeck H, Bscheider M, Dostert C, Hannesschlager N et al (2009) Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 459:433–6CrossRefPubMedGoogle Scholar
  27. 27.
    Steele C, Rapaka RR, Metz A, Pop SM, Williams DL et al (2005) The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus. PLoS Pathog 1:e42CrossRefPubMedCentralPubMedGoogle Scholar
  28. 28.
    Saijo S, Fujikado N, Furuta T, Chung SH, Kotaki H et al (2007) Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat Immunol 8:39–46CrossRefPubMedGoogle Scholar
  29. 29.
    Vautier S, Drummond RA, Redelinghuys P, Murray GI, MacCallum DM et al (2012) Dectin-1 is not required for controlling Candida albicans colonization of the gastrointestinal tract. Infect Immun 80:4216–22CrossRefPubMedCentralPubMedGoogle Scholar
  30. 30.
    Ferwerda B, Ferwerda G, Plantinga TS, Willment JA, van Spriel AB et al (2009) Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 361:1760–7CrossRefPubMedCentralPubMedGoogle Scholar
  31. 31.
    Glocker EO, Hennigs A, Nabavi M, Schaffer AA, Woellner C et al (2009) A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 361:1727–35CrossRefPubMedCentralPubMedGoogle Scholar
  32. 32.
    Cunha C, Di Ianni M, Bozza S, Giovannini G, Zagarella S et al (2010) Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. Blood 116:5394–402CrossRefPubMedGoogle Scholar
  33. 33.
    Iliev ID, Funari VA, Taylor KD, Nguyen Q, Reyes CN et al (2012) Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 336:1314–7CrossRefPubMedCentralPubMedGoogle Scholar
  34. 34.
    Robinson MJ, Osorio F, Rosas M, Freitas RP, Schweighoffer E et al (2009) Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection. J Exp Med 206:2037–51CrossRefPubMedCentralPubMedGoogle Scholar
  35. 35.
    Saijo S, Ikeda S, Yamabe K, Kakuta S, Ishigame H et al (2010) Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity 32:681–91CrossRefPubMedGoogle Scholar
  36. 36.
    Gringhuis SI, Wevers BA, Kaptein TM, van Capel TM, Theelen B et al (2011) Selective C-Rel activation via Malt1 controls anti-fungal T (H)-17 immunity by dectin-1 and dectin-2. PLoS Pathog 7:e1001259CrossRefPubMedCentralPubMedGoogle Scholar
  37. 37.
    de Sousa MDT, Belda W, Spina R, Lota PR, Valente NS et al (2014) Topical application of imiquimod as a treatment for chromoblastomycosis. Clin Infect Dis 58:1734–7CrossRefPubMedCentralGoogle Scholar
  38. 38.
    Wells CA, Salvage-Jones JA, Li X, Hitchens K, Butcher S et al (2008) The macrophage-inducible C-type lectin, Mincle, is an essential component of the innate immune response to Candida albicans. J Immunol 180:7404–13CrossRefPubMedGoogle Scholar
  39. 39.
    Ishikawa E, Ishikawa T, Morita YS, Toyonaga K, Yamada H et al (2009) Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J Exp Med 206:2879–88CrossRefPubMedCentralPubMedGoogle Scholar
  40. 40.
    Sousa Mda G, Reid DM, Schweighoffer E, Tybulewicz V, Ruland J et al (2011) Restoration of pattern recognition receptor costimulation to treat chromoblastomycosis, a chronic fungal infection of the skin. Cell Host Microbe 9:436–43CrossRefPubMedGoogle Scholar
  41. 41.
    Yamasaki S, Matsumoto M, Takeuchi O, Matsuzawa T, Ishikawa E et al (2009) C-type lectin Mincle is an activating receptor for pathogenic fungus, Malassezia. Proc Natl Acad Sci U S A 106:1897–902CrossRefPubMedCentralPubMedGoogle Scholar
  42. 42.
    Gringhuis SI, den Dunnen J, Litjens M, van Het Hof B, van Kooyk Y et al (2007) C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. Immunity 26:605–16CrossRefPubMedGoogle Scholar
  43. 43.
    Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Geijtenbeek TB (2009) Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat Immunol 10:1081–8CrossRefPubMedGoogle Scholar
  44. 44.
    Zenaro E, Donini M, Dusi S (2009) Induction of Th1/Th17 immune response by Mycobacterium tuberculosis: role of dectin-1, mannose receptor, and DC-SIGN. J Leukoc Biol 86:1393–401CrossRefPubMedGoogle Scholar
  45. 45.
    Marr KA, Carter RA, Boeckh M, Martin P, Corey L (2002) Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 100:4358–66CrossRefPubMedGoogle Scholar
  46. 46.
    Sainz J, Lupianez CB, Segura-Catena J, Vazquez L, Rios R et al (2012) Dectin-1 and DC-SIGN polymorphisms associated with invasive pulmonary Aspergillosis infection. PloS One 7:e32273CrossRefPubMedCentralPubMedGoogle Scholar
  47. 47.
    Gazi U, Rosas M, Singh S, Heinsbroek S, Haq I et al (2011) Fungal recognition enhances mannose receptor shedding through Dectin-1 engagement. J Biol Chem 286:7822–9CrossRefPubMedCentralPubMedGoogle Scholar
  48. 48.
    Gales A, Conduche A, Bernad J, Lefevre L, Olagnier D et al (2010) PPAR gamma controls Dectin-1 expression required for host antifungal defense against Candida albicans. PLoS Pathog 6Google Scholar
  49. 49.
    Dan JM, Kelly RM, Lee CK, Levitz SM (2008) Role of the mannose receptor in a murine model of Cryptococcus neoformans infection. Infect Immun 76:2362–7CrossRefPubMedCentralPubMedGoogle Scholar
  50. 50.
    Bellocchio S, Montagnoli C, Bozza S, Gaziano R, Rossi G et al (2004) The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol 172:3059–69CrossRefPubMedGoogle Scholar
  51. 51.
    Netea MG, Van Der Graaf CA, Vonk AG, Verschueren I, Van Der Meer JW et al (2002) The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J Infect Dis 185:1483–9CrossRefPubMedGoogle Scholar
  52. 52.
    Villamon E, Gozalbo D, Roig P, O’Connor JE, Fradelizi D et al (2004) Toll-like receptor-2 is essential in murine defenses against Candida albicans infections. Microbes Infect 6:1–7CrossRefPubMedGoogle Scholar
  53. 53.
    Netea MG, Gow NA, Joosten LA, Verschueren I, van der Meer JW et al (2010) Variable recognition of Candida albicans strains by TLR4 and lectin recognition receptors. Med Mycol 48:897–903CrossRefPubMedGoogle Scholar
  54. 54.
    Picard C, von Bernuth H, Ghandil P, Chrabieh M, Levy O et al (2010) Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine 89:403–25CrossRefPubMedCentralPubMedGoogle Scholar
  55. 55.
    Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN et al (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25:187–91CrossRefPubMedGoogle Scholar
  56. 56.
    Pamer EG (2008) TLR polymorphisms and the risk of invasive fungal infections. N Engl J Med 359:1836–8CrossRefPubMedCentralPubMedGoogle Scholar
  57. 57.
    Bochud PY, Chien JW, Marr KA, Leisenring WM, Upton A et al (2008) Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med 359:1766–77CrossRefPubMedCentralPubMedGoogle Scholar
  58. 58.
    Carvalho A, Pasqualotto AC, Pitzurra L, Romani L, Denning DW et al (2008) Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis. J Infect Dis 197:618–21CrossRefPubMedGoogle Scholar
  59. 59.
    Dennehy KM, Ferwerda G, Faro-Trindade I, Pyz E, Willment JA et al (2008) Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors. Eur J Immunol 38:500–6CrossRefPubMedCentralPubMedGoogle Scholar
  60. 60.
    Dennehy KM, Willment JA, Williams DL, Brown GD (2009) Reciprocal regulation of IL-23 and IL-12 following co-activation of Dectin-1 and TLR signaling pathways. Eur J Immunol 39:1379–86CrossRefPubMedCentralPubMedGoogle Scholar
  61. 61.
    Brown GD, Herre J, Williams DL, Willment JA, Marshall AS et al (2003) Dectin-1 mediates the biological effects of beta-glucans. J Exp Med 197:1119–24CrossRefPubMedCentralPubMedGoogle Scholar
  62. 62.
    Ohtani M, Iyori M, Saeki A, Tanizume N, Into T et al (2011) Involvement of suppressor of cytokine signalling-1-mediated degradation of MyD88-adaptor-like protein in the suppression of Toll-like receptor 2-mediated signalling by the murine C-type lectin SIGNR1-mediated signalling. Cell Microbiol 14:40–57CrossRefPubMedGoogle Scholar
  63. 63.
    Takahara K, Tokieda S, Nagaoka K, Inaba K (2011) Efficient capture of Candida albicans and zymosan by SIGNR1 augments TLR2-dependent TNF-alpha production. Int Immunol 24:89–96CrossRefPubMedGoogle Scholar
  64. 64.
    Takahara K, Tokieda S, Nagaoka K, Takeda T, Kimura Y et al (2011) C-type lectin SIGNR1 enhances cellular oxidative burst response against C. albicans in cooperation with Dectin-1. Eur J Immunol 41:1435–44CrossRefPubMedGoogle Scholar
  65. 65.
    Ameen M (2009) Chromoblastomycosis: clinical presentation and management. Clin Exp Dermatol 34:849–54CrossRefPubMedGoogle Scholar
  66. 66.
    Empey KM, Hollifield M, Garvy BA (2007) Exogenous heat-killed Escherichia coli improves alveolar macrophage activity and reduces Pneumocystis carinii lung burden in infant mice. Infect Immun 75:3382–93CrossRefPubMedCentralPubMedGoogle Scholar
  67. 67.
    Steele C, Shellito JE, Kolls JK (2005) Immunity against the opportunistic fungal pathogen Pneumocystis. Med Mycol 43:1–19CrossRefPubMedGoogle Scholar
  68. 68.
    Lobato-Pascual A, Saether PC, Fossum S, Dissen E, Daws MR (2013) Mincle, the receptor for mycobacterial cord factor, forms a functional receptor complex with MCL and FcepsilonRI-gamma. Eur J Immunol 43:3167–74CrossRefPubMedGoogle Scholar
  69. 69.
    Yamasaki S (2013) Signaling while eating: MCL is coupled with Mincle. Eur J Immunol 43:3156–8CrossRefPubMedGoogle Scholar
  70. 70.
    Wevers BA, Kaptein TM, Zijlstra-Willems EM, Theelen B, Boekhout T et al (2014) Fungal engagement of the C-type lectin mincle suppresses dectin-1-induced antifungal immunity. Cell Host Microbe 15:494–505CrossRefPubMedGoogle Scholar
  71. 71.
    Hise AG, Tomalka J, Ganesan S, Patel K, Hall BA et al (2009) An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 5:487–97CrossRefPubMedCentralPubMedGoogle Scholar
  72. 72.
    Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783–801CrossRefPubMedGoogle Scholar
  73. 73.
    Said-Sadier N, Padilla E, Langsley G, Ojcius DM (2010) Aspergillus fumigatus stimulates the NLRP3 inflammasome through a pathway requiring ROS production and the Syk tyrosine kinase. PloS one 5Google Scholar
  74. 74.
    Joly S, Ma N, Sadler JJ, Soll DR, Cassel SL et al (2009) Cutting edge: Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome. J Immunol 183:3578–81CrossRefPubMedCentralPubMedGoogle Scholar
  75. 75.
    van de Veerdonk FL, Joosten LA, Shaw PJ, Smeekens SP, Malireddi RK et al (2011) The inflammasome drives protective Th1 and Th17 cellular responses in disseminated candidiasis. Eur J Immunol 41:2260–8CrossRefPubMedCentralPubMedGoogle Scholar
  76. 76.
    Tomalka J, Ganesan S, Azodi E, Patel K, Majmudar P et al (2011) A novel role for the NLRC4 inflammasome in mucosal defenses against the fungal pathogen Candida albicans. PLoS Pathog 7:e1002379CrossRefPubMedCentralPubMedGoogle Scholar
  77. 77.
    Gringhuis SI, Kaptein TM, Wevers BA, Theelen B, van der Vlist M et al (2012) Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1beta via a noncanonical caspase-8 inflammasome. Nat Immunol 13:246–54CrossRefPubMedGoogle Scholar
  78. 78.
    Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL et al (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123–32CrossRefPubMedGoogle Scholar
  79. 79.
    Park H, Li Z, Yang XO, Chang SH, Nurieva R et al (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6:1133–41CrossRefPubMedCentralPubMedGoogle Scholar
  80. 80.
    Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC et al (2009) Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31:331–41CrossRefPubMedGoogle Scholar
  81. 81.
    Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27:485–517CrossRefPubMedGoogle Scholar
  82. 82.
    Zheng SG (2013) Regulatory T cells vs Th17: differentiation of Th17 versus Treg, are the mutually exclusive? Am J Clin Exp Immunol 2:94–106PubMedCentralPubMedGoogle Scholar
  83. 83.
    Tesmer LA, Lundy SK, Sarkar S, Fox DA (2008) Th17 cells in human disease. Immunol Rev 223:87–113CrossRefPubMedCentralPubMedGoogle Scholar
  84. 84.
    Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Wevers B et al (2009) Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappaB activation through Raf-1 and Syk. Nat Immunol 10:203–13CrossRefPubMedGoogle Scholar
  85. 85.
    Martin B, Hirota K, Cua DJ, Stockinger B, Veldhoen M (2009) Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31:321–30CrossRefPubMedGoogle Scholar
  86. 86.
    Drummond RA, Brown GD (2011) The role of Dectin-1 in the host defence against fungal infections. Curr Opin Microbiol 14:392–9CrossRefPubMedGoogle Scholar
  87. 87.
    Hernandez-Santos N, Gaffen SL (2012) Th17 cells in immunity to Candida albicans. Cell Host Microbe 11:425–35CrossRefPubMedCentralPubMedGoogle Scholar
  88. 88.
    Rudner XL, Happel KI, Young EA, Shellito JE (2007) Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect Immun 75:3055–61CrossRefPubMedCentralPubMedGoogle Scholar
  89. 89.
    Zelante T, De Luca A, Bonifazi P, Montagnoli C, Bozza S et al (2007) IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 37:2695–706CrossRefPubMedGoogle Scholar
  90. 90.
    Huppler AR, Conti HR, Hernandez-Santos N, Darville T, Biswas PS, et al. Role of neutrophils in IL-17-dependent immunity to mucosal candidiasis. J Immunol 192: 1745–52Google Scholar
  91. 91.
    Bar E, Whitney PG, Moor K, Reis e Sousa C, LeibundGut-Landmann S. 2014. IL-17 regulates systemic fungal immunity by controlling the functional competence of NK cells. Immunity 40: 117–27Google Scholar
  92. 92.
    Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ et al (2008) Impaired T (H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452:773–6CrossRefPubMedCentralPubMedGoogle Scholar
  93. 93.
    Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L et al (2011) Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332:65–8CrossRefPubMedCentralPubMedGoogle Scholar
  94. 94.
    van de Veerdonk FL, Plantinga TS, Hoischen A, Smeekens SP, Joosten LA et al (2011) STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med 365:54–61CrossRefPubMedGoogle Scholar
  95. 95.
    Seider K, Heyken A, Luttich A, Miramon P, Hube B (2010) Interaction of pathogenic yeasts with phagocytes: survival, persistence and escape. Curr Opin Microbiol 13:392–400CrossRefPubMedGoogle Scholar
  96. 96.
    Miramon P, Kasper L, Hube B (2013) Thriving within the host: Candida spp. interactions with phagocytic cells. Med Microbiol Immunol 202:183–95CrossRefPubMedGoogle Scholar
  97. 97.
    Chai LYA, Netea MG, Vonk AG, Kullberg BJ (2009) Fungal strategies for overcoming host innate immune response. Med Mycol 47:227–36CrossRefPubMedGoogle Scholar
  98. 98.
    Heinsbroek SEM, Brown GD, Gordon S (2005) Dectin-1 escape by fungal dimorphism. Trends Immunol 26:352–4CrossRefPubMedGoogle Scholar
  99. 99.
    Sato K, Yang XL, Yudate T, Chung JS, Wu J et al (2006) Dectin-2 is a pattern recognition receptor for fungi that couples with the Fc receptor gamma chain to induce innate immune responses. J Biol Chem 281:38854–66CrossRefPubMedGoogle Scholar
  100. 100.
    Rappleye CA, Eissenberg LG, Goldman WE (2007) Histoplasma capsulatum alpha-(1,3)-glucan blocks innate immune recognition by the beta-glucan receptor. Proc Natl Acad Sci U S A 104:1366–70CrossRefPubMedCentralPubMedGoogle Scholar
  101. 101.
    Sloan DJ, Parris V (2014) Cryptococcal meningitis: epidemiology and therapeutic options. Clin Epidemiol 6:169–82CrossRefPubMedCentralPubMedGoogle Scholar
  102. 102.
    Jain N, Li L, McFadden DC, Banarjee U, Wang X et al (2006) Phenotypic switching in a Cryptococcus neoformans variety gattii strain is associated with changes in virulence and promotes dissemination to the central nervous system. Infect Immun 74:896–903CrossRefPubMedCentralPubMedGoogle Scholar
  103. 103.
    Panepinto JC, Komperda KW, Hacham M, Shin S, Liu XG et al (2007) Binding of serum mannan binding lectin to a cell integrity-defective Cryptococcus neoformans ccr4 Delta mutant. Infect Immun 75:4769–79CrossRefPubMedCentralPubMedGoogle Scholar
  104. 104.
    Voelz K, May RC (2010) Cryptococcal interactions with the host immune system. Eukaryotic Cell 9:835–46CrossRefPubMedCentralPubMedGoogle Scholar

Copyright information

© The Author(s) 2014

Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.

Authors and Affiliations

  • Anthony Plato
    • 1
  • Sarah E. Hardison
    • 1
  • Gordon D. Brown
    • 1
    Email author
  1. 1.Division of Applied Medicine Immunity, Infection and Inflammation Programme Room 4.20, Institute of Medical SciencesAshgrove Road West University of AberdeenAberdeenUK

Personalised recommendations